Companies
Upside Foods
a Californian pioneer that holds FDA and USDA clearance for a whole-textured cultivated-chicken fillet and runs 2,000-litre production batches at its EPIC engineering centre, funded by a $400M Series C round in 2022.
- Country
- United States
FDA/USDA
ISO 22000
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $608 million - $609 million raised since 2015 | agfundernews.com |
| Capacity | 50,000 lbs per year at EPIC facility, with potential to scale to 400,000 lbs/year | agfundernews.com |
| Certification | USDA Grant of Inspection for production facilities; FDA green light for cultivated meat safety | agfundernews.com · reuters.com · virgin.com |
| Regulatory approval | FDA safety determination and USDA approval to sell cultivated chicken and use 'cell cultivated chicken' on labels | agfundernews.com · reuters.com · virgin.com |
| Production site | EPIC facility in Emeryville, California | agfundernews.com |
| Revenue | $63.3 million in 2026 medium confidence | incfact.com |
Independent sources: agfundernews.com · incfact.com · reuters.com · virgin.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cultivated meat | food-alt-protein | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.